The trajectory of companies tied to the drug's past presents a complex investment picture . While the initial success generated substantial gains, generic competition have significantly eroded revenue. https://knockoff942767.blogchaat.com/42065815/copyright-s-flagship-product-and-big-pharma-a-risky-investment